Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stada to complete acquisition of Russia's Nizhpharm

This article was originally published in Scrip

Executive Summary

Stadahas asked minority shareholders ofNizhpharm, its subsidiary in Russia, to sell their shares at a price of Rb12,051 ($493.3) each, and Nizhpharm’s board has recommended that they accept the proposal. The German company has owned a 99.1% stake in Nizhpharm, one of Russia’s most advanced pharmaceutical manufacturers, since 2005.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC000975

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel